On-Demand Webinars
-
Streamlining Drug Development: From Developability Assessment To High-Concentration Formulation Development
6/19/2025
Explore a strategic approach to accelerating biologics formulation by gaining early insight into molecular properties and optimizing high-concentration conditions with minimal protein input.
-
Unlocking Efficiency In Large-Scale Microbial Manufacturing
6/16/2025
Gain insights into how expert teams and the right tools help build resilience into manufacturing systems and tackle small, often-overlooked issues before they become costly problems.
-
The Role Of Developability In Lead Candidate Selection
6/12/2025
Discover how developability assessments are crucial for identifying biologic candidates that are both effective and manufacturable, thereby reducing risks and improving the chances of clinical success.
-
Flexibility To Meet Your Process Needs
6/11/2025
Explore a platform that adapts to your evolving workflow through real-world examples of how its flexibility supports diverse inputs, applications, and parameters to ensure consistency, scalability, and efficiency.
-
Prevent Batch Failures Before They Happen
6/11/2025
Discover a platform that reduces operator errors and batch failures through automation, real-time monitoring, and intelligent design to ensure greater process reliability and consistent outcomes in your workflow.
-
Easy Integration Of A New Manufacturing Platform
6/11/2025
Easily integrate an innovative platform into your manufacturing process with seamless onboarding, regulatory support, and expert guidance that is designed to help you confidently adopt good manufacturing practices.
-
Optimizing The Progression Of Biotherapeutic Candidates To FIH Studies
6/9/2025
Learn actionable strategies that can lead to higher success rates and smarter resource investment, paving the way for a successful path to IND submissions and commercialization.
-
Simplify CAR-T Cell Manufacturing With LNP-Mediated Delivery
6/3/2025
Streamline CAR-T cell manufacturing with lipid nanoparticles delivering base editors to create fratricide-resistant, CD45-edited CAR45 T cells, which enables scalable, precise, and potent therapies for blood cancers.
-
A New Look At Subcutaneous mAb Delivery Using Nanoformed Particles
6/3/2025
A highly concentrated non-aqueous suspension of an IgG1 was developed using a patented platform. Review how the particle size of the monoclonal antibody (mAb) impacts the overall behavior of the drug product.
-
The Advantages Of Off-The-Shelf GMP iPSCs With A DMF
6/2/2025
Learn how off-the-shelf, GMP-grade iPSC lines with a Drug Master File (DMF) can accelerate cell therapy development, streamline regulatory approval, and reduce time and cost to clinic.